Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Neuroscience Letters|October 18, 2002
Methylene blue restores spatial memory retention impaired by an inhibitor of cytochrome oxidase in ratsNarriman Lee Callaway, Penny D Riha, Kathryn M Wrubel, et al.
The American Journal of Cardiology|October 7, 2006
COMPARE: comparison of the effects of carvedilol CR and carvedilol IR on left ventricular ejection fraction in patients with heart failureBarry H Greenberg, Mandeep Mehra, John R Teerlink, et al.
Clinical Colorectal Cancer|July 21, 2010
Referral patterns and adjuvant chemotherapy use in patients with stage II colon cancerHaskell M Kirkpatrick, Cristi L Aitelli, Huanying Qin, et al.
Journal of the National Cancer Institute|August 8, 2002
Outcomes and toxicity in african-american and caucasian patients in a randomized adjuvant chemotherapy trial for colon cancerA David McCollum, Paul J Catalano, Daniel G Haller, et al.
European Journal of Cancer (Oxford, England : 1990)|June 11, 2013
Results of docetaxel plus oxaliplatin (DOCOX) ± cetuximab in patients with metastatic gastric and/or gastroesophageal junction adenocarcinoma: results of a randomised Phase 2 studyDonald Richards, Darren M Kocs, Alexander I Spira, et al.
American Journal of Clinical Oncology|December 15, 2004
Lack of efficacy of streptozocin and doxorubicin in patients with advanced pancreatic endocrine tumorsA David McCollum, Matthew H Kulke, David P Ryan, et al.
Sustainability Science|December 15, 2018
Mapping interactions between the sustainable development goals: lessons learned and ways forwardMåns Nilsson, Elinor Chisholm, David Griggs, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 3, 2013
A phase II study with cetuximab and radiation therapy for patients with surgically resectable esophageal and GE junction carcinomas: Hoosier Oncology Group G05-92Carlos R Becerra, Nasser Hanna, Andrew David McCollum, et al.
American Journal of Clinical Oncology|February 8, 2006
The combination of capecitabine and thalidomide in previously treated, refractory metastatic colorectal cancerA David McCollum, Bingyan Wu, Jeffrey W Clark, et al.
Head & Neck|September 25, 2004
Positron emission tomography with 18F-fluorodeoxyglucose to predict pathologic response after induction chemotherapy and definitive chemoradiotherapy in head and neck cancerA David McCollum, Steven C Burrell, Robert I Haddad, et al.
Pageof 3